The Associations between Plasma Betatrophin Level and C-Peptide in Type 2 Diabetic and Nondiabetics

被引:0
|
作者
Abu-Farha, Mohamed
Abubaker, Jehad
Al-Khairi, Irina
Cheri-An, Preethi
Noronha, Fiona
Al-Arouj, Monira
Behbehani, Kazem
Bennakhi, Abdullah
Elkum, Naser
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2916-PO
引用
收藏
页码:A733 / A733
页数:1
相关论文
共 50 条
  • [31] Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General Population
    Sokooti, Sara
    Kieneker, Lyanne M.
    de Borst, Martin H.
    Muller Kobold, Anneke
    Kootstra-Ros, Jenny E.
    Gloerich, Jolein
    van Gool, Alain J.
    Heerspink, Hiddo J. Lambers
    Gansevoort, Ron T.
    Dullaart, Robin P. F.
    Bakker, Stephan J. L.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 13
  • [32] ROLE OF PLASMA C-PEPTIDE MEASUREMENT IN PREDICTING THE NEED FOR LATER INSULIN THERAPY IN TYPE-2 DIABETIC SUBJECTS
    KELLER, U
    PASQUEL, M
    BERGER, W
    DIABETES, 1986, 35 : A91 - A91
  • [33] Cord blood C-peptide level in newborns of diabetic mothers.
    WenderOzegowska, E
    Pietryga, M
    Meissner, W
    Hausz, K
    Biczysko, R
    DIABETOLOGIA, 1997, 40 : 861 - 861
  • [34] Age at Diagnosis and C-Peptide Level Are Associated with Diabetic Retinopathy in Chinese
    Cai, Xiaoling
    Han, Xueyao
    Zhang, Simin
    Luo, Yingying
    Chen, Yingli
    Ji, Linong
    PLOS ONE, 2014, 9 (03):
  • [35] Relationship between C-peptide levels and diabetic neuropathy in type 1 diabetic patients after islet transplantation
    Maffi, P
    Furiani, S
    Castelnuovo, A
    Di Carlo, V
    Galardi, G
    Pozza, G
    DIABETES, 1999, 48 : A55 - A55
  • [36] Frequency of type I and II diabetes in newly diagnosed diabetic patients: Measuring C-Peptide level
    Shahbazian, Hajieh
    Aleali, Armaghan Moravej
    Rashidi, Homeira
    Latifi, Seyed Mahmoud
    Rashidi, Mojtaba
    Yazdanpanah, Leila
    Zaman, Ferdos
    Payami, Seyed Peyman
    Moradi, Leila
    Jahanshahi, Alireza
    Sedaghat, Alireza
    Zakerkish, Mehrnoosh
    Moradi, Mitra
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (03) : 1833 - 1835
  • [37] DETERMINING C-PEPTIDE LEVEL IN TYPE-1 DIABETES
    ZUPPINGER, K
    BUETTI, L
    GALLINO, L
    AEBI, C
    THERAPEUTISCHE UMSCHAU, 1983, 40 (10) : 840 - 844
  • [38] Genotypic Associations with C-Peptide Persistence in People with Type 1 Diabetes
    Mckeigue, Paul
    Spiliopoulou, Athina
    Mcgurnaghan, Stuart
    Colombo, Marco
    Mcdonald, Timothy J.
    Colhoun, Helen
    DIABETES, 2018, 67
  • [39] Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide
    Elbassuoni, Eman A.
    Aziz, Neven M.
    El-Tahawy, Nashwa F.
    APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2018, 43 (06) : 617 - 624
  • [40] Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type-2 diabetes mellitus
    Inukai, T
    Matsutomo, R
    Tayama, K
    Aso, Y
    Takemura, Y
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 (01) : 40 - 45